Alain Sanchez, MD

The most dangerous phrase in our language is “we have always done it this way”

In lupus nephritis (LN), “activity” gets the spotlight—but chronic scarring often decides the long game. So: which chronicity score best predicts outcomes—NIH Chronicity Index (NIH-CI) or the Mayo Clinic Chronicity Score (MCCS)? buff.ly/tvebmPZ

@AAcosta_MedMD @DanaFarber @MayoHemeOnc @Ash @DrCCutler Congratulations!! 🎉🎈🍾

Excited to share I will be joining @DanaFarber as their 2027 Advanced BMT fellow 🥳🫣 Thank you to my mentors @MayoHemeOnc and @ash CRTI for the incredible support! Incredibly appreciative of Drs Gooptu, @DrCCutler, Soiffer & Antin for the vote of confidence… CAN’T WAIT!! 🎉🎉

🫁 ERS/EULAR 2026 CTD-ILD Guidelines — Key Takeaways 🔹 Covers SSc, RA, IIM, Sjögren, SLE & MCTD–ILD 🔹 Built on 25 PICO + 28 narrative questions using GRADE methodology 📌 Screening 👉 HRCT = gold standard 🚫 Do NOT replace HRCT with PFTs or lung ultrasound (high miss rates) ✅ Screen ALL SSc & MCTD ✅ Screen RA / SjD / IIM if risk factors present 📌 Baseline risk assessment Assess globally using: • HRCT extent/pattern • FVC + DLCO • Autoantibodies • CRP/ESR • Clinical severity 📌 Monitoring 🔁 PFTs every 3–6 months initially, then 6–12 monthly 🔁 HRCT: • SSc/RA: every 1–2 yrs • IIM (high-risk): as early as 3–6 months 📌 Treatment recommendations 🟢 SSc-ILD • Tocilizumab (strong) • MMF / Rituximab / Cyclophosphamide (conditional) • Nintedanib for progressive fibrosis • MMF + Nintedanib combination allowed 🟢 IIM-ILD • Immunosuppression strongly recommended 🟢 RA / SjD / SLE / MCTD-ILD • Immunosuppressants suggested • RA-ILD (UIP): Pirfenidone may help 🟢 Progressive fibrosing CTD-ILD • Add Nintedanib 🚫 Lung biopsy NOT routine ✅ BAL only if infection / alternate dx suspected ✅ PROMs + 6MWT for severity/prognosis ⸻ 🔥 TAKE-HOME MESSAGE Early HRCT screening + structured monitoring + timely immunosuppression/antifibrotics = cornerstone of CTD-ILD care. Missing ILD = missed survival opportunity. ⸻ 📄 Eur Respir J 2026 DOI: 10.1183/13993003.02533-2024 #CTDILD #InterstitialLungDisease #Rheumatology #Pulmonology #SystemicSclerosis #RA #Myositis #Sjogrens #SLE #ERS #EULAR #ILD #MedTwitter #RheumTwitter #PulmTwitter

Volver a México y compartir con colegas siempre es una alegría: colegas increíbles, preguntas buenísimas y mucha conversación. Gracias al Colegio Mexicano de Reumatología por la invitación. 🇲🇽

Call for new applicants for Rheum With a (re)View—a mentoring program focused on cultivating manuscript reviewers for the ACR’s 3 scientific journals. ACR/ARP members with research experience are encouraged to apply by March 31 ▶️ Details → rheumatology.org/acr-journals-p…

🆕 2025 ACR Guideline for Treatment of Systemic #Lupus Erythematosus 🦋 Just Released: Nov 3 #ACR25 🔥 🔸Review organ-specific treatment recommendations 🔸Steroid & HCQ Use Guidance ➠ Read the Full Guideline: acr.tw/47mkegj #RheumX #RheumTwitter #Rheum @RheumNow

Now published: The 2025 ACR Guideline for the Treatment of Systemic Lupus Erythematosus 📄 Read the paper: acr.tw/47mkegj ℹ️ See additional content and resources on this guideline at acr.tw/4mbHK4W

@ACRheum @ACR_Journals Thanks so much for this opportunity! You guys are great!

NEW EPISODE! Alain Sanchez-Rodriguez, MD, joins the podcast to discuss delays in #lupus diagnosis & care based on findings from the Lupus Midwest Network (LUMEN)🎙️LISTEN NOW → acr.tw/3UWKCXi @ACR_Journals

Thanks so much for this opportunity!! sites.libsyn.com/436041/lumen

Over 20 years have passed since the ACR last issued a broad treatment guideline for #SLE. In our NEWEST episode, Lisa R. Sammaritano, MD, summarizes the major updates in the soon-to-be-released 2025 guideline.🎙️LISTEN → acr.tw/4mTmpNi

Acaso soy una anciana que le duele el tobillo?

#ESOC2025 🏃🏻‍♀️ESCAPE MEVO sub analysis 👉🏻 prognosis by image 🧠 👉🏻EVT <12 hs not > good functional outcome 👉🏻 Good collateral status > benefit 👉🏻 ⏱️<180 min > benefit

1/ 🧵The 2024 ACR Guidelines for Lupus Nephritis (LN) are here! Big shifts in screening, combo therapy, and steroid minimization. Let's break it down. Full text: acrjournals.onlinelibrary.wiley.com/doi/epdf/10.10…

Now published simultaneously in AC&R + A&R, the 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis See ACR guideline page for resources - rheumatology.org/lupus-guideline DOI link - doi.org/10.1002/acr.25… Download the article - acr.tw/44sRwJM

@luccyferpeutz Chi

Hace dos años una señora iba a consulta con su hija, antes de entrar le dijeron a mi asistente que irían por pan afuera. Y ya no volvieron. Hoy me escriben por la cita de seguimiento. ¿Será que me traen pan?

@CarlosBaOch Uffff 💰 🤑

Jamás pensé que podría vivir de creación de contenido 😂😂😂😂😂

Welcome Jaime! 🤩⭐️🤩⭐️

Rheumatologist when someone automatically calls an ANA (+) “undifferentiated connective tissue disease”

@JoseMeadeMD Jajajajajajajajaja